News

Results published demonstrating accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging

Zurich-Schlieren, Switzerland, March 9, 2023. Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, today announced that new results evaluating Proclarix® in combination with imaging were published in BJU International[1]. The early detection of clinically significant prostate cancer decreases prostate cancer mortality. The use of multiparametric magnetic resonance imaging...

read more

Fostering Interactions in Biotech: Navignostics

7th of March, 16.15-17.00 Auditorium Bio Technopark Schlieren, Wagistrasse 25, 8952 Schlieren Are you working in biotech and love to hear about exciting science, discuss innovative ideas and learn about struggles and creative solutions? So do we! Engaging discussions and collaborations are invaluable for productive science, innovation and for creating new, disruptive ideas. This...

read more